TFF Pharmaceuticals Announces Second Patient Successfully Treated with Voriconazole Inhalation Powder Through Compassionate Use Program
Marks the Second Patient to Clinically Benefit from Administration of Voriconazole Inhalation Powder Using Thin Film Freezing-Based Technology Positive Results from First Patient Treated with TFF... | November 1, 2022
Source: marketscreener.com